Google has teamed up with Swiss pharmaceutical company Novartis to develop smart contact lenses designed to help diabetics. The search giant unveiled the plans at Google X earlier this year. The lens uses non-invasive sensors to analyze tear fluid and provide measurements of the wearer's glucose levels. This information is sent to the user's mobile device to help them manage their diabetes easier.
Novartis has licensed the technology and will develop it into a commercial product through their eye-care subsidiary Alcon.
Google co-founder Sergey Brin said they are "very excited to work with Novartis [on using] the latest technology in the miniaturization of electronics to help improve the quality of life for millions of people."
Novartis hopes to move this product beyond monitoring glucose levels to help users "restore the eye's natural autofocus" by possibly implanting lenses directly into eyes.